Skip Navigation

European Journal of Heart Failure 2001 3(5):535-543; doi:10.1016/S1388-9842(01)00160-X
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (8)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Scheuermann-Freestone, M.
Right arrow Articles by Willenbrock, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Scheuermann-Freestone, M.
Right arrow Articles by Willenbrock, R.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2001 European Society of Cardiology

A new model of congestive heart failure in the mouse due to chronic volume overload

Michaela Scheuermann-Freestonea,*, Nicholas Simon Freestoneb, Thomas Langenickela, Klaus Höhnela, Rainer Dietza and Roland Willenbrocka

a Franz-Volhard Clinic, Laboratory of Clinical and Experimental Heart Failure, Max Delbrück Center for Molecular Medicine Berlin, Germany
b The Rayne Institute, Cardiovascular Research, St. Thomas' Hospital London, UK

* Corresponding author. Present Address. Department of Cardiovascular Medicine, John Radcliffe Hospital, Oxford, UK. Tel.: +44-1865-221875; fax: +44-1865-768844. E-mail address: mscheuer{at}bioch.ox.ac.uk (M. Scheuermann-Freestone)


   Abstract

Objective: Recently, deletion of specific genes by so called knock-out techniques has become important for investigating the pathogenesis of various diseases. This form of genetic engineering is widely performed in murine models. There are, however, only a limited number of mouse models available in cardiovascular pathology. The objective of this study, therefore, was to develop a new model of overt congestive heart failure associated with myocardial hypertrophy in the mouse.

Methods: Female C57/BL6 mice weighing 19–20 g were anesthetized with ether. After abdominal incision, the aorta was temporarily clamped proximal to the renal arteries. The aorta was then punctured with a needle (outer diameter 0.6 mm) and the needle was further advanced into the adjacent vena cava. After withdrawal of the needle, the aortic puncture site was sealed with cyanoacrylate glue. The clamp was removed, and the patency of the shunt was visually verified as swelling and mixing of venous and arterial blood in the vena cava. Sham-operated mice served as controls.

Results: Perioperative mortality of mice with aortocaval shunt was 42%. Four weeks after shunt induction, mice showed a significant cardiac hypertrophy with a relative heart weight of 7.5 ± 0.2 mg/100 g body weight (vs. 5.1 ± 0.7 mg/100 g in control mice, P < 0.001). While no changes in blood pressure and heart rate occurred, left ventricular enddiastolic pressure was significantly increased in mice with shunt, and left ventricular contractility was impaired from 6331 ± 412 to 4170 ± 296 mmHg/s (P < 0.05). Plasma concentrations of atrial natriuretic peptide (ANP) and its second messenger cGMP as humoral markers of heart failure as well as ventricular expression of ANP - and brain natriuretic peptide (BNP)-mRNA were significantly increased in mice with shunt compared to control mice.

Conclusions: The aortocaval shunt in the mouse constitutes a new model of overt congestive heart failure with impaired hemodynamic parameters and may be a useful tool to investigate the role of particular genes in the development of heart failure.

Key Words: Heart failure • Pathophysiology • Hemodynamics • Mouse • Natriuretic peptides

Received October 3, 2000; Revised February 20, 2001; Accepted April 26, 2001


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
C.-F. Lam, T. E. Peterson, D. M. Richardson, A. J. Croatt, L. V. d'Uscio, K. A. Nath, and Z. S. Katusic
Increased blood flow causes coordinated upregulation of arterial eNOS and biosynthesis of tetrahydrobiopterin
Am J Physiol Heart Circ Physiol, February 1, 2006; 290(2): H786 - H793.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
D. F. Alvarez, J. A. King, and M. I. Townsley
Resistance to Store Depletion-induced Endothelial Injury in Rat Lung after Chronic Heart Failure
Am. J. Respir. Crit. Care Med., November 1, 2005; 172(9): 1153 - 1160.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
T. Nishikimi, J. R. Hagaman, N. Takahashi, H.-S. Kim, H. Matsuoka, O. Smithies, and N. Maeda
Increased susceptibility to heart failure in response to volume overload in mice lacking natriuretic peptide receptor-A gene
Cardiovasc Res, April 1, 2005; 66(1): 94 - 103.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
Q. Wang, H. R. Brunner, and M. Burnier
Determination of cardiac contractility in awake unsedated mice with a fluid-filled catheter
Am J Physiol Heart Circ Physiol, February 1, 2004; 286(2): H806 - H814.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
A. Ponten, X. Li, P. Thoren, K. Aase, T. Sjoblom, A. Ostman, and U. Eriksson
Transgenic Overexpression of Platelet-Derived Growth Factor-C in the Mouse Heart Induces Cardiac Fibrosis, Hypertrophy, and Dilated Cardiomyopathy
Am. J. Pathol., August 1, 2003; 163(2): 673 - 682.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.